Marshall Wace North America’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-13,508
Closed -$1.28M 1753
2018
Q3
$1.28M Sell
13,508
-380,203
-97% -$32.4M 0.01% 568
2018
Q2
$30.4M Sell
393,711
-428,136
-52% -$32.1M 0.17% 138
2018
Q1
$56.8M Sell
821,847
-251,699
-23% -$19.2M 0.28% 82
2017
Q4
$80.1M Buy
+1,073,546
New +$68.7M 0.44% 45
2017
Q3
Sell
-28,645
Closed -$1.83M 1658
2017
Q2
$1.83M Buy
+28,645
New +$1.8M 0.01% 763
2013
Q3
Sell
-4,308
Closed -$266K 747
2013
Q2
$266K Buy
+4,308
New +$259K 0.02% 372

Other funds holding ESRX

Marshall Wace North America's ESRX Position: Q4 2018 in Review

Marshall Wace North America sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 13,508 shares — an estimated $1.28M sold.

Marshall Wace North America first reported a position in ESRX in Q2 2013 and held it in 6 quarters. The position peaked at $80.1M in Q4 2017. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Marshall Wace North America reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Marshall Wace North America sold 13,508 Express Scripts Holding Company shares in Q4 2018, an estimated $1.28M.
  • Marshall Wace North America first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 6 quarters.
  • Marshall Wace North America's Express Scripts Holding Company position peaked at $80.1M in Q4 2017.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Marshall Wace North America's 13F filing for Q4 2018, filed 14 Feb 2019.